Literature DB >> 17010669

Proteolytic mapping of the adeno-associated virus capsid.

Kim Van Vliet1, Veronique Blouin, Mavis Agbandje-McKenna, Richard O Snyder.   

Abstract

The three-dimensional structures of the viral capsid of three AAV serotypes have previously been determined by X-ray crystallography or cryoelectron microscopy. These studies of AAV and similar studies of autonomous parvoviruses have yielded important structural information about the virions in a low-energy conformation. However, there is little information on the structural properties of AAV virions in solution under physiological conditions. We demonstrate that proteolytic digestion of AAV2 virions with trypsin results in cleavage at a specific site on the capsid surface while the capsid remains intact. The products of digestion were mapped using unique antibodies, protein sequencing, mass spectroscopy, and 3D structure modeling to a region on a surface loop that is common to all three AAV2 structural proteins. Empty AAV2 capsids could be distinguished from full (DNA-containing) capsids, having an increased susceptibility of VP2 to trypsin and being digested more rapidly by chymotrypsin. Proteolytic analysis utilizing trypsin or chymotrypsin was also capable of distinguishing AAV2 from AAV1 and AAV5, as seen by differential susceptibility and unique fragment patterns. These data demonstrate a novel approach for studying the structure of AAV capsids in solution and should be valuable in the testing and engineering of AAV vectors for gene transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010669      PMCID: PMC1808542          DOI: 10.1016/j.ymthe.2006.08.1222

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

1.  Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.

Authors:  H Stedman; J M Wilson; R Finke; A L Kleckner; J Mendell
Journal:  Hum Gene Ther       Date:  2000-03-20       Impact factor: 5.695

2.  Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

Authors:  Sergei Zolotukhin; Mark Potter; Irene Zolotukhin; Yoshihisa Sakai; Scott Loiler; Thomas J Fraites; Vince A Chiodo; Tina Phillipsberg; Nicholas Muzyczka; William W Hauswirth; Terance R Flotte; Barry J Byrne; Richard O Snyder
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

3.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

4.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids.

Authors:  S Kronenberg; J A Kleinschmidt; B Böttcher
Journal:  EMBO Rep       Date:  2001-11       Impact factor: 8.807

6.  Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.

Authors:  Atsushi Handa; Shin-Ichi Muramatsu; Jianming Qiu; Hiroaki Mizukami; Kevin E Brown
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

7.  Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.

Authors:  C E Wobus; B Hügle-Dörr; A Girod; G Petersen; M Hallek; J A Kleinschmidt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Authors:  M L Aitken; R B Moss; D A Waltz; M E Dovey; M R Tonelli; S C McNamara; R L Gibson; B W Ramsey; B J Carter; T C Reynolds
Journal:  Hum Gene Ther       Date:  2001-10-10       Impact factor: 5.695

9.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

Review 10.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

View more
  11 in total

1.  Detecting small changes and additional peptides in the canine parvovirus capsid structure.

Authors:  Christian D S Nelson; Eveliina Minkkinen; Magnus Bergkvist; Karin Hoelzer; Mathew Fisher; Brian Bothner; Colin R Parrish
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

2.  Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material.

Authors:  Martin Lock; Susan McGorray; Alberto Auricchio; Eduard Ayuso; E Jeffrey Beecham; Véronique Blouin-Tavel; Fatima Bosch; Mahuya Bose; Barry J Byrne; Tina Caton; John A Chiorini; Abdelwahed Chtarto; K Reed Clark; Thomas Conlon; Christophe Darmon; Monica Doria; Anne Douar; Terence R Flotte; Joyce D Francis; Achille Francois; Mauro Giacca; Michael T Korn; Irina Korytov; Xavier Leon; Barbara Leuchs; Gabriele Lux; Catherine Melas; Hiroaki Mizukami; Philippe Moullier; Marcus Müller; Keiya Ozawa; Tina Philipsberg; Karine Poulard; Christina Raupp; Christel Rivière; Sigrid D Roosendaal; R Jude Samulski; Steven M Soltys; Richard Surosky; Liliane Tenenbaum; Darby L Thomas; Bart van Montfort; Gabor Veres; J Fraser Wright; Yili Xu; Olga Zelenaia; Lorena Zentilin; Richard O Snyder
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

3.  Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material.

Authors:  Eduard Ayuso; Véronique Blouin; Martin Lock; Susan McGorray; Xavier Leon; Mauricio R Alvira; Alberto Auricchio; Stephanie Bucher; Abdelwahed Chtarto; K Reed Clark; Christophe Darmon; Monica Doria; Will Fountain; Guangping Gao; Kai Gao; Mauro Giacca; Juergen Kleinschmidt; Barbara Leuchs; Catherine Melas; Hiroaki Mizukami; Marcus Müller; Yvet Noordman; Olivier Bockstael; Keiya Ozawa; Catherine Pythoud; Marina Sumaroka; Richard Surosky; Liliane Tenenbaum; Inge van der Linden; Brigitte Weins; J Fraser Wright; Xinhua Zhang; Lorena Zentilin; Fatima Bosch; Richard O Snyder; Philippe Moullier
Journal:  Hum Gene Ther       Date:  2014-11       Impact factor: 5.695

4.  Evidence for pH-dependent protease activity in the adeno-associated virus capsid.

Authors:  Maxim Salganik; Balasubramanian Venkatakrishnan; Antonette Bennett; Bridget Lins; Joseph Yarbrough; Nicholas Muzyczka; Mavis Agbandje-McKenna; Robert McKenna
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

5.  Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus.

Authors:  Jarrod S Johnson; R Jude Samulski
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

6.  Comparative analysis of adeno-associated virus capsid stability and dynamics.

Authors:  Vamseedhar Rayaprolu; Shannon Kruse; Ravi Kant; Balasubramanian Venkatakrishnan; Navid Movahed; Dewey Brooke; Bridget Lins; Antonette Bennett; Timothy Potter; Robert McKenna; Mavis Agbandje-McKenna; Brian Bothner
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

7.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.

Authors:  Deniz Dalkara; Kathleen D Kolstad; Natalia Caporale; Meike Visel; Ryan R Klimczak; David V Schaffer; John G Flannery
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

8.  The capsid proteins of Aleutian mink disease virus activate caspases and are specifically cleaved during infection.

Authors:  Fang Cheng; Aaron Yun Chen; Sonja M Best; Marshall E Bloom; David Pintel; Jianming Qiu
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

9.  Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales.

Authors:  Alejandro Negrete; Robert M Kotin
Journal:  J Virol Methods       Date:  2007-07-02       Impact factor: 2.014

Review 10.  The role of the adeno-associated virus capsid in gene transfer.

Authors:  Kim M Van Vliet; Veronique Blouin; Nicole Brument; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Methods Mol Biol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.